Iowa City Va Medical Research Foundation is located in Iowa City, IA. The organization was established in 1998. As of 12/2023, Iowa City VA Medical Research Foundation employed 6 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Iowa City VA Medical Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Iowa City VA Medical Research Foundation generated $668.8k in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 1.8% each year. All expenses for the organization totaled $914.0k during the year ending 12/2023. While expenses have increased by 4.6% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO MOBILIZE RESOURCES TO IMPROVE THE HEALTH AND WELL BEING OF THE VETERAN COMMUNITY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
IOWA CITY VA MEDICAL RESEARCH FOUNDATION (ICVARF) MOBILIZES RESOURCES THAT HELP IMPROVE VETERANS' HEALTHCARE, EDUCATION, AND LIVES. BASED IN IOWA CITY, A HUB OF RESEARCH AND HEALTH CARE IN THE MIDWEST, WE SERVE VETERANS IN IOWA AND EASTERN ILLINOIS. ICVARF HELPS THE IOWA CITY VA HEALTH CARE SYSTEM ADVANCE ITS HEALTHCARE GOALS. ICVARF SUPPORTS MEDICAL RESEARCH PROJECTS LED BY PRINCIPAL INVESTIGATORS AND STAFF TO ASSIST AND IMPROVE THE HEALTHCARE PROVIDED TO THE VETERAN COMMUNITY.FOR THE YEAR ENDING DECEMBER 31, 2023, THE FOUNDATION CONTINUED TO MANAGE MORE THAN 10 GRANTS AND PROJECTS. DURING 2023, THE FOUNDATION COMPLETED 3 NEW PRECLINICAL CRADAS: 1. A CRADA NOVARTIS TO STUDY STATIN COMPLIANCE IN VETERANS DIAGNOSED WITH CARDIOVASCULAR DISEASE, 2. A PRECLINICAL CRADA WITH HARLINGENE LIFE SCIENCES TO ASSESS NEUROTOXICITY OF NOVEL COMPOUNDS IN A RAT MODEL, AND 3. A BASIC SCIENCE CRADA WITH CASTLE BIOSCIENCE TO STUDY MELANOMA BIOMARKERS IN VOLUNTEER VETERAN BIOPSIES. DURING 2023, THE FOUNDATION ALSO COMPLETED AN AMENDMENT WITH AN EXPANDED BUDGET AND SCOPE FOR OUR EXISTING NOVO NORDISK CRADA. BY THE END OF 2023, THE FOUNDATION HAD SUCCESSFULLY COMPLETED YEAR 3 OF THE NIH ALL OF US GRANT. THE RECRUITMENT METRICS FOR THE YEAR MET THE PROJECTED GOALS. ALSO, DURING 2023, THE FOUNDATION SUCCESSFULLY ADMINISTERED THE DOD CONTRACT W81XWH2010811, A GRANT AIMED AT STUDYING BLOOD-BASED BIOMARKERS OF PARKINSON'S DISEASE IN VETERANS, FULLY COMPLIANT IN THE FEDERAL GRANTS ADMINISTRATION PORTALS WITH SUCCESSFUL SUBMISSION OF INVOICES. THE FOUNDATION SUCCESSFULLY ADMINISTERED THE ONGOING CRADA WITH DR. GOTO AND MERCK TO STUDY PNEUMOCOCCAL AND INFLUENZA VACCINATION OUTCOMES IN VETERANS, WITH AGREEMENTS ESTABLISHED TO COVER SALARIES FOR UNIVERSITY OF IOWA BIOSTATISTICIANS. THE EXECUTIVE DIRECTOR OF THE FOUNDATION ATTENDED NAVREF'S EXECUTIVE DIRECTOR ESSENTIAL TRAINING 2-DAY COURSE IN SAN DIEGO IN MARCH 2023, AS WELL AS THE ANNUAL NAVREF MEETING IN ST PAUL, MINNESOTA, IN SEPTEMBER, 2023.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Yorek Dr Mark Chair | OfficerTrustee | 2 | $0 |
Mikelson John Secretary/treasurer | OfficerTrustee | 2 | $0 |
Johnson-Mekota Judith Director | Trustee | 2 | $0 |
Kline Dr Joel Director | Trustee | 2 | $0 |
Parker Dr Stanley Director | Trustee | 2 | $0 |
Points Kari Director | Trustee | 2 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $385 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $385 |
Total Program Service Revenue | $664,851 |
Investment income | $3,601 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $668,837 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $147,880 |
Compensation of current officers, directors, key employees. | $147,880 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $258,871 |
Pension plan accruals and contributions | $19,691 |
Other employee benefits | $22,638 |
Payroll taxes | $25,603 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $18,358 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $4,855 |
Advertising and promotion | $0 |
Office expenses | $15,006 |
Information technology | $17,015 |
Royalties | $0 |
Occupancy | $0 |
Travel | $17,332 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $3,320 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $0 |
Total functional expenses | $913,958 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $1,211,950 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $84,967 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $1,296,917 |
Accounts payable and accrued expenses | $100,334 |
Grants payable | $0 |
Deferred revenue | $676,695 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $777,029 |
Net assets without donor restrictions | $519,888 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $1,296,917 |